Lipigon Pharmaceuticals AB
LPGO SE0015382072
ICB 2010 : Health Care / Health CareAnnual Performance 1
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -53% | -90% | -46% | -70% | -12% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Johan Living CEO |
0.14 SEK |
10,000 Sold |
1,395 SEK |
28/07/2025 | 25/07/2025 |
| Johan Living CEO |
0.14 SEK |
252,128 Sold |
34,668 SEK |
28/07/2025 | 25/07/2025 |
| Johan Living CEO |
0.14 SEK |
22,704 Sold |
3,145 SEK |
28/07/2025 | 25/07/2025 |
| Johan Living CEO |
0.14 SEK |
3,480 Sold |
485 SEK |
28/07/2025 | 25/07/2025 |
| Johan Living CEO |
0.14 SEK |
2,043 Sold |
294 SEK |
28/07/2025 | 25/07/2025 |
| Johan Living CEO |
0.14 SEK |
5,000 Sold |
693 SEK |
28/07/2025 | 25/07/2025 |
| Johan Living CEO |
0.14 SEK |
20,216 Sold |
2,800 SEK |
28/07/2025 | 25/07/2025 |
| Johan Living CEO |
0.14 SEK |
28,880 Sold |
4,000 SEK |
28/07/2025 | 25/07/2025 |
| Johan Living CEO |
0.14 SEK |
137,749 Sold |
19,216 SEK |
28/07/2025 | 25/07/2025 |
| Johan Living CEO |
0.14 SEK |
50,000 Sold |
7,200 SEK |
28/07/2025 | 24/07/2025 |